ENCell Co Ltd
KOSDAQ:456070
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ENCell Co Ltd
Intangible Assets
ENCell Co Ltd
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
ENCell Co Ltd
KOSDAQ:456070
|
Intangible Assets
₩264.7m
|
CAGR 3-Years
34%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Samsung Biologics Co Ltd
KRX:207940
|
Intangible Assets
₩3.7T
|
CAGR 3-Years
-5%
|
CAGR 5-Years
176%
|
CAGR 10-Years
N/A
|
|
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
Intangible Assets
₩184.3m
|
CAGR 3-Years
-43%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Intangible Assets
₩3.2B
|
CAGR 3-Years
68%
|
CAGR 5-Years
37%
|
CAGR 10-Years
10%
|
|
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Intangible Assets
₩5.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Intangible Assets
₩88.4B
|
CAGR 3-Years
124%
|
CAGR 5-Years
61%
|
CAGR 10-Years
20%
|
|
ENCell Co Ltd
Glance View
ENCell Co Ltd is a KR-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Seoul, Seoul. The company went IPO on 2024-08-23. ENCell Co Ltd is a Korea-based company principally engaged in the development and research of new drugs. The firm is principally engaged in the development and research of cell and gene-based biopharmaceuticals. The firm is also engaged in the provision of biopharmaceutical quality testing services. In addition, the Company is engaged in the biopharmaceutical consignment production business.
See Also
What is ENCell Co Ltd's Intangible Assets?
Intangible Assets
264.7m
KRW
Based on the financial report for Dec 31, 2024, ENCell Co Ltd's Intangible Assets amounts to 264.7m KRW.
What is ENCell Co Ltd's Intangible Assets growth rate?
Intangible Assets CAGR 3Y
34%
Over the last year, the Intangible Assets growth was -9%. The average annual Intangible Assets growth rates for ENCell Co Ltd have been 34% over the past three years .
